TotalMarketCap

Obsidian Therapeutics

OBXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$620.200 M

$10.04 -8.64%

Close of 6 Nov 2026

As of 6 Nov 2026, Obsidian Therapeutics (OBX) has a market capitalization of $620.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$100.6M

Loss-making

Shares outstanding

61,772,876

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #169Evotec SEEVO$626.1M
  2. #170Design TherapeuticsDSGN$624.4M
  3. #171Obsidian TherapeuticsOBX$620.2M
  4. #172Adlai Nortye GroupANL$619.5M
  5. #173Helus PharmaHELP$613.7M

What if Obsidian Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$457,107.97

Per share 45,529× higher

Bitcoin $1.53T

$24,733.32

Per share 2,463× higher

Apple $5.02T

$81,197.17

Per share 8,087× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Obsidian Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.